Stay updated on Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error with a minimal header and a Home link. Most study-related content and navigational elements are absent on this page, indicating the record is not currently accessible.
    Difference
    20%
    Check dated 2026-09-23T20:55:54.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision updated from v3.6.6 to v3.7.0, indicating a new version of the page. The update represents a metadata refresh rather than a change to study information.
    Difference
    0.1%
    Check dated 2026-09-16T22:05:34.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.5 to v3.6.6, representing a minor update to the page's version information.
    Difference
    0.1%
    Check dated 2026-09-02T19:59:08.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Added Revision: v3.6.5 and removed Revision: v3.6.4, indicating the page now reflects a newer document version. This is a small versioning update rather than a substantive change to the study details.
    Difference
    0.1%
    Check dated 2026-08-12T01:48:32.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.3 to v3.6.4, indicating a new version of the page. There are no visible updates to the study details or associated information.
    Difference
    0.1%
    Check dated 2026-07-21T22:57:43.000Z thumbnail image
  7. Check
    98 days ago
    Change Detected
    Summary
    The page's revision tag changed from v3.6.0 to v3.6.3, representing an update to the page's versioning metadata rather than a change to study details.
    Difference
    0.1%
    Check dated 2026-06-30T10:22:20.000Z thumbnail image

Stay in the know with updates to Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page.